Login / Signup

Bacterial Polyhydroxyalkanoates-based Therapeutics-delivery Nanosystems.

Esteban F Durán-LaraDiana RafaelFernanda AndradeOlga Lobos GSekar Vijayakumar
Published in: Current medicinal chemistry (2023)
Microbial polyhydroxyalkanoates (PHAs) are bio-based aliphatic biopolyester produced by bacteria as an intracellular storage material of carbon and energy under stressed conditions. PHAs have been paid attention to due to their unique and impressive biological properties including high biodegradability, biocompatibility, low cytotoxicity, and different mechanical properties. Under this context, the development of drug-delivery nanosystems based on PHAs has been revealed to have numerous advantages compared with synthetic polymers that included biocompatibility, biodegradability, non-toxic, and low-cost production, among others. In this review article, we present the available state of the art of PHAs. Moreover, we discussed the potential benefits, weaknesses, and perspectives of PHAs to the develop drug delivery systems.
Keyphrases
  • low cost
  • drug delivery
  • microbial community
  • single cell
  • cancer therapy
  • reactive oxygen species
  • risk assessment
  • tissue engineering